Prognostic utility of neutrophil-to-albumin ratio in surgically treated oral squamous cell carcinoma
© 2023 Wiley Periodicals LLC..
BACKGROUND: We aimed to evaluate the prognostic significance of preoperative neutrophil-to-albumin ratio (NAR) in oral squamous cell carcinoma (OSCC).
METHODS: A total of 622 patients with surgically treated OSCC were enrolled. NAR was defined as the absolute neutrophil count divided by the serum albumin level in peripheral blood before the radical surgery. Cox proportional hazards model were used to discover survival outcome-associated factors.
RESULTS: The optimal cut-off of NAR to predict overall survival (OS) was determined to be 0.1. In Cox model, high NAR was identified as an independent negative prognosticator of OS, cancer-specific survival, and recurrence-free survival (adjusted hazard ratio: 1.503, 1.958, and 1.727, respectively; all p < 0.05). The NAR-based nomogram accurately predicted OS (concordance index: 0.750).
CONCLUSION: Our study suggests that preoperative NAR is a convenient and effective prognostic marker for OSCC and NAR-based nomogram can be a promising prognostic tool in clinical setting.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
|---|---|
| Enthalten in: |
Head & neck - 45(2023), 11 vom: 11. Nov., Seite 2839-2850 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yu, Ya-Yun [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Absolute neutrophil count |
|---|
| Anmerkungen: |
Date Completed 23.10.2023 Date Revised 23.10.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/hed.27511 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361959257 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361959257 | ||
| 003 | DE-627 | ||
| 005 | 20231226090237.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/hed.27511 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1206.xml |
| 035 | |a (DE-627)NLM361959257 | ||
| 035 | |a (NLM)37698535 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yu, Ya-Yun |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prognostic utility of neutrophil-to-albumin ratio in surgically treated oral squamous cell carcinoma |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.10.2023 | ||
| 500 | |a Date Revised 23.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 Wiley Periodicals LLC. | ||
| 520 | |a BACKGROUND: We aimed to evaluate the prognostic significance of preoperative neutrophil-to-albumin ratio (NAR) in oral squamous cell carcinoma (OSCC) | ||
| 520 | |a METHODS: A total of 622 patients with surgically treated OSCC were enrolled. NAR was defined as the absolute neutrophil count divided by the serum albumin level in peripheral blood before the radical surgery. Cox proportional hazards model were used to discover survival outcome-associated factors | ||
| 520 | |a RESULTS: The optimal cut-off of NAR to predict overall survival (OS) was determined to be 0.1. In Cox model, high NAR was identified as an independent negative prognosticator of OS, cancer-specific survival, and recurrence-free survival (adjusted hazard ratio: 1.503, 1.958, and 1.727, respectively; all p < 0.05). The NAR-based nomogram accurately predicted OS (concordance index: 0.750) | ||
| 520 | |a CONCLUSION: Our study suggests that preoperative NAR is a convenient and effective prognostic marker for OSCC and NAR-based nomogram can be a promising prognostic tool in clinical setting | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a absolute neutrophil count | |
| 650 | 4 | |a albumin | |
| 650 | 4 | |a neutrophil-to-albumin ratio | |
| 650 | 4 | |a oral cancer | |
| 650 | 4 | |a prognosis | |
| 650 | 7 | |a Albumins |2 NLM | |
| 700 | 1 | |a Lin, Yu-Tsai |e verfasserin |4 aut | |
| 700 | 1 | |a Chuang, Hui-Ching |e verfasserin |4 aut | |
| 700 | 1 | |a Chien, Chih-Yen |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Tai-Lin |e verfasserin |4 aut | |
| 700 | 1 | |a Fang, Fu-Min |e verfasserin |4 aut | |
| 700 | 1 | |a Tsai, Yao-Te |e verfasserin |4 aut | |
| 700 | 1 | |a Lu, Hui |e verfasserin |4 aut | |
| 700 | 1 | |a Tsai, Ming-Hsien |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Head & neck |d 1996 |g 45(2023), 11 vom: 11. Nov., Seite 2839-2850 |w (DE-627)NLM012791806 |x 1097-0347 |7 nnns |
| 773 | 1 | 8 | |g volume:45 |g year:2023 |g number:11 |g day:11 |g month:11 |g pages:2839-2850 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/hed.27511 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 45 |j 2023 |e 11 |b 11 |c 11 |h 2839-2850 | ||